BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 24, 2009
View Archived Issues
GW-3965 improves cognition in impaired mice
Read More
Tapentadol extended release shows efficacy and safety in phase III study of chronic pain
Read More
Phase I results for IVN-201 for cat dander allergy announced by ImVisioN
Read More
Vardenafil improves continence after prostatectomy; LUTS in benign prostatic hyperplasia patients
Read More
Shire voluntarily recalls Daytrana transdermal patch due to release liner defect
Read More
FDA approves Lexapro for major depressive disorder in adolescents
Read More
SkyePharma files NDA for Flutiform with the FDA
Read More
Merck Frosst Canada presents novel renin inhibitors
Read More
Allergan reports novel pyrrole compounds for the treatment of glaucoma
Read More
Clinical trial results for MB-07803 in type 2 diabetes reported by Metabasis
Read More
CHMP recommends marketing authorization for HRA's emergency contraceptive ellaOne
Read More
Novel clinical candidate for type 2 diabetes treatment described by Amgen
Read More
Novel histamine H3 receptor antagonist presented by Pfizer
Read More
Injection of adenovirus expressing SkM1 demonstrates antiarrhythmic activity
Read More
Micromet initiates phase II adecatumumab trial in colorectal cancer patients
Read More
Nereus Pharmaceuticals has begun a phase II trial of NPI-2358 in NSCLC
Read More
Transition initiates phase Ib TT-223/GLP-1 analogue study in type 2 diabetes
Read More
CHMP recommends marketing authorization for Astellas' Modigraf in transplant rejection
Read More
Oryzon acquires Crystax
Read More
NMRC submits revised IND to FDA to conduct RESUS clinical trial of Biopure's Hemopure
Read More
FDA approves Symbyax for treatment-resistant depression
Read More
Exalgo extended-release meets primary efficacy endpoint in phase III trial
Read More
Torii to launch Remitch in Japan for pruritus in hemodialysis
Read More
Vertex Pharmaceuticals claims novel protein kinase inhibitors
Read More
Roche presents novel pyrrolodine aryl-ether compounds
Read More
